A multi-center, phase 1-2A, open-label, dosage-escalation and randomized, double-blinded, placebo-controlled study of dimebon [dimebolin] in subjects with Huntington's disease.

Status: Completed

Phase of Trial: Phase I/II

Latest Information Update: 18 Apr 2009

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

14 Apr 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
19 Feb 2008 Status changed from completed to in progress as Medivation have reported that the phase II part is ongoing.
19 Feb 2008 Medivation have reported that the phase I tolerability part of this trial has been completed.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com